Sichuan Maker Biotechnology Co. Ltd. A | Ownership
Companies that own Sichuan Maker Biotechnology Co. Ltd. A
ICBC Credit Suisse Asset Management Co., Ltd.
10,000,070
2.73%
10,000,070
0.47%
09/30/2017
Norges Bank Investment Management
4,761,847
1.3%
4,761,847
0%
12/31/2017
GF Fund Management Co., Ltd.
3,951,779
1.08%
-4,039,644
0.17%
12/31/2017
E Fund Management Co., Ltd.
2,876,784
0.78%
-290,079
0.07%
12/31/2017
HuaAn Fund Management Co., Ltd.
1,754,694
0.48%
1,241,801
0.08%
12/31/2017
Baoying Fund Management Co., Ltd.
1,739,903
0.47%
374,024
0.23%
12/31/2017
The Caisse de dépôt et placement du Québec
1,660,532
0.45%
1,660,532
0.01%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
1,530,355
0.42%
1,145,316
0.4%
12/31/2017
Bosera Asset Management Co., Ltd.
1,196,000
0.33%
-2,461,291
0.03%
12/31/2017
Fullgoal Fund Management Co., Ltd.
871,991
0.24%
871,991
0.03%
12/31/2017
| Address |
8 Anhe 2nd Road
Chengdu Sichuan 611731
China
|
|
Employees
|
- |
| Website |
http://www.maccura.com |
| Updated |
07/08/2019 |
| Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. Its products include clinical chemistry reagents and equipment, chemiluminescence instruments and reagents, testing and analysis products, and hematology products. The company was founded by Deng Ming Wang on October 20, 1994 and is headquartered in Chengdu, China. |
